Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG 1 1For a complete list of the members of the Children’s Oncology Group Soft Tissue Sarcoma Committee (formerly Intergroup Rhabdomyosarcoma Group) representing the Children’s Oncology Group and the Quality Assurance Review Center, see the Appendix.Sarah S. Donaldson, Moody D. Wharam, Jane L. Meza et al.|International Journal of Radiation Oncology*Biology*Physics|2001Cited by 213
Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IVJeff M. Michalski, Sarah S. Donaldson, Jane L. Meza et al.|International Journal of Radiation Oncology*Biology*Physics|2004Cited by 112
Local Control With Reduced-Dose Radiotherapy for Low-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group D9602 StudyJohn C. Breneman, Douglas S. Hawkins, Jane L. Meza et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 78
Effect of Radiotherapy Techniques (IMRT vs. 3D-CRT) on Outcome in Patients With Intermediate-Risk Rhabdomyosarcoma Enrolled in COG D9803—A Report From the Children’s Oncology GroupChi Lin, John C. Breneman, Sarah S. Donaldson et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 72
Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancerShantibhusan Senapati, Surinder K. Batra, Hemant K. Roy et al.|British Journal of Cancer|2008Cited by 39